1. Executive Summary 2. Research Methodology 3. Introduction 4. Diabetes 4.1.1 Overview 4.1.2 Cost – Human & Financial 5. Insulin Market 5.1 Overview 5.2 Market Analysis 5.2.1 Market Sizing (Actual & Forecasted) 5.2.2 Market Share by Insulin Type 5.2.3 Market Share by Segment 5.2.4 Market Share by Region 6. Insulin Delivery Devices 6.1 Overview 6.2 Vial and syringe 6.2.1 Overview 6.2.2 Market Sizing (Actual & Forecasted) 6.3 Insulin pen 6.3.1 Overview 6.3.2 Market Sizing (Actual & Forecasted) 6.4 Insulin Pump 6.4.1Overview 6.4.1 Market Sizing (Actual & Forecasted) 6.5 Others 6.6 Market Share Analysis 6.6.1 Market Share by Devices 6.6.2 Market Share by End-User 6.6.3 Market Share by Region 7. Regional/ Country Analysis 7.1 Europe 7.1.1 Overview 7.1.2 Market Sizing (Actual & Forecasted) 7.1.3 Market Share 7.2 North America and Caribbean 7.2.1 Overview 7.2.2 Market Sizing (Actual & Forecasted) 7.2.3 Market Share 7.4 China 7.4.1 Overview 7.4.2 Market Sizing (Actual & Forecasted) 7.4.3 Market Share 8. Pricing Analysis 9. Global Insulin Market Dynamics 9.1 Industry Trends & Developments 9.1.1 Dominance of Modern and New-Generation Insulin 9.1.2 Advent of Intelligent Insulin Pens 9.1.3 Sensor-augmented Pump Therapy 9.1.4 Approval of Glargine Basaglar – The First “Biosimilar” Insulin in the US 9.3 Growth Drivers 9.3.1 Increasing Prevelance of Diabetes 9.3.2 Rise in Geriatric Population 9.3.3 Growing Obese Population 9.3.4 Propogation of Diabetes Management Awareness 9.3.5 Government Impetus 9.4 Challenges 9.4.1 High Cost of Insulin 9.4.2 Insurance Coverage issue 9.4.3 High Competition 9.4.4 Regulatory Pressure 10. Competitive Landscape 10.1 Market Share by Competitors 10.2 Market Share by Drug Brands 11. Company Profiles 11.1 Novo Nordisk 11.2 Sanofi Aventis 11.3 Eli Lilly and Company 11.4 Merck & Co.

Figure 1: Rockville Research – Research Methodology Figure 2: Top ten countries/territories for Number of Adults with Diabetes Figure 3: Global Diabetes Care Market by Treatment Class, 2011-15 (US$ Millions) Figure 4: Insulin Production and Action Figure 5: Global Insulin Market Size by Value, 2011-16E (US$ Billions) Figure 6: Global Insulin Market Size by Value Forecasted, 2017E-22E (US$ Billions) Table 1: Insulin and Diabetes Drugs Approved Between 2012-2016 Figure 7: Global Insulin Market Share by Type (2015) Table 2: Worldwide Sales of Various Types of Insulin, 2015 (US$ Billions) Figure 8: Global Insulin Market (Volume) Share by Segment (2016) Figure 9: Global Insulin Market (Volume) Share by Region (2015) Figure 10: Global Insulin Syringes Market Size by Value, 2014-22E (US$ Billions) Figure 11: Global Insulin Pumps Market Size by Value, 2014-22E (US$ Billions) Figure 12: Global Insulin Pens Market Size by Value, 2014-22E (US$ Billions) Figure 13: Global Insulin Injectors Market Size by Value, 2014-22E (US$ Billions) Table 3: Top Insulin Pump Comparisons Table 4: Comparison of Insulin Pumps and Insulin Pens Figure 14: Global Insulin Delivery Devices Market Share by Product, 2014-22E (US$ Million) Figure 15: Global Insulin Delivery Devices Market Share by End-User, 2016 & 2022E Figure 16: Insulin Delivery Devices Market Share by Region (2015) Figure 17: Global Insulin Delivery Devices Market Share by Region, 2016 & 2022E Table 5: Europe Diabetes Statistics Figure 18: Europe - Insulin Market Size by Value, 2011-16E (US$ Billions) Figure 19: Europe - Insulin Market Size by Value Forecasted, 2017E-22E (US$ Billions) Figure 20: Europe – Insulin Market Share by Insulin Type (2015) Table 6: North America Diabetes Statistics Figure 21: The US - Insulin Market Size by Value, 2011-16E (US$ Billion) Figure 22: The US - Insulin Market Size by Value Forecasted, 2017E-22E (US$ Billion) Figure 23: The US – Insulin Market (Volume) Share by TRx, 2011 & 2015 Figure 24: The US – Insulin Market Share by Insulin Type (2015) Table 7: China Diabetes Statistics Figure 25: China - Insulin Market Size by Value, 2011-16E (US$ Billion) Figure 26: China - Insulin Market Size by Value Forecasted, 2017E-22E (US$ Billion) Figure 27: China – Insulin Market Share by Insulin Type (2015) Figure 28: Worldwide Insulin Price Comparison, Cost per vial of Insulin (Feb’2016) Figure 29: Worldwide Insulin Cost Increment, 2005 vs. 2015 Table 8: Prices of Popular Insulins Figure 30: Cost of Insulin, Jul’1996 – Jul’2016 Figure 31: Intelligent Insulin Pens Connectivity through Different Methods Figure 32: Worldwide Diabetes Incidence by Region, 2015 & 2040E (Millions) Figure 33: Prevalence of people with diabetes by age and sex, 2015 Figure 34: Global Obese Population, 2000-2016 Table 9: Proportion of Undiagnosed Diabetic Population Aged (20-79 years), 2015 Table 10: Coverage of Popular Insulin Drug Brands Figure 35: Global Diabetes Care Market (Value) Share by Competitors (2016) Figure 36: Global Modern Insulin Volume Market Share by Competitors (2016) Figure 37: Global Insulin Unit Share by Drug Brands (2016) Figure 38: Global Basal Insulin Market Share by Drug Brands (2015) Figure 39: Global Rapid-Action Insulin Market Share by Drug Brands (2015) Figure 40: Novo Nordisk Diabetes and Obesity Care Sales by Segment, FY2012-FY2016 (US$ Billion) Table 11: Novo Nordisk – Diabetes R&D Pipeline Table 12: Sanofi Aventis Diabetes Pipeline Figure 41: Sanofi Aventis Net Sales, FY2012-FY2016 (US$ Billion) Table 13: Eli Lilly and Company Clinical Development Pipeline Table 14: Merck & Co. Product Pipeline Figure 42: Merck & Co. Revenue by Business Segment (FY2016) Figure 43: Merck & Co. Net Sales, FY2012-FY2016 (US$ Billion)

Novo Nordisk, Sanofi Aventis, Eli Lilly and Company; and Merck & Co.